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Background: Pre-procedural elevated platelet activation represents an important prognostic factor in patients undergoing percutaneous 
coronary intervention (PCI). Nitric Oxide suppresses platelet aggregation, leucocyte migration and cellular adhesion to the endothelium. Asymmetric 
dimethylarginine (ADMA), an endogenous competitive inhibitor of Nitric Oxide Synthase, is a cause of endothelial dysfunction and a predictor of 
occurrence of acute coronary events. The aim of this study was to evaluate the correlation of ADMA serum levels with residual platelet reactivity after 
clopidogrel administration in patients (pts) undergoing PCI
Methods: A total of 136 pts were prospectively enrolled and divided in two groups according to pre-procedural serum ADMA levels measured by 
high performance liquid chromatography (73 pts with ADMA ≤ 0.70 mmol/L e 63 pts with ADMA > 0.70 mmol/L). Platelet inhibition was measured 
by the VerifyNow P2Y12 assay and expressed as P2Y12 reaction units (PRU). Clopidogrel non responsiveness was defined as pre-procedural PRU > 
240.
Results: The mean serum ADMA concentration was 0.63±0.08 mmol/L in the first group and 0.92±0.15 mmol/L in the second one (p< 0.001). 
Considering pre-procedural PRU levels, 65 pts with PRU < 240 showed a significant lower ADMA concentration versus 71 pts with PRU > 240 
(0.71±0.16 vs 0.81±0.21 mmol/L, p = 0.001). Moreover, the rate of clopidogrel responders (pre-procedural PRU < 240) was higher (59% vs 39%, p 
= 0.005) and values of PRU were lower (234±56 vs 266±55, p = 0.033) in ADMA ≤ 0.70 mmol/L group
Conclusions: This is the first study demonstrating the correlation between high serum ADMA levels and residual platelet reactivity after clopidogrel 
administration. Thus, ADMA may be considered an useful tool to optimize anti-platelet therapy in patients undergoing PCI
